Literature DB >> 21532482

Ill-health and intellectual disabilities.

Jane McCarthy1, Jean O'Hara.   

Abstract

PURPOSE OF REVIEW: Adults with intellectual disabilities are recognized globally as a group of individuals with poorer access to appropriate healthcare and have worse health outcomes than the general population, including significantly reduced life expectancy. This article reviews the evidence base published over the past 12-24 months, highlighting how public health policy is influencing the literature on the health needs of people with intellectual disabilities. RECENT
FINDINGS: Recent studies looking at information from death certificates found people with intellectual disabilities died 15 years younger than people without intellectual disabilities. Using standardized mortality rates, the overall mortality for people with intellectual disabilities is three times higher than for the general population. People with intellectual disabilities have higher rates of asthma and oral disease, but similar rates of hypertension. There is limited high-quality evidence on drugs used to treat epilepsy in this population, despite epilepsy being one of the leading causes of premature deaths.
SUMMARY: Recent evidence continues to show that people with intellectual disabilities have poorer health outcomes than the general population. However, the quality of evidence available on the wider health needs remains limited, but, with the move to a public health approach through health surveillance, this may increase the quality of evidence available, so influencing health outcomes for people with intellectual disabilities.

Entities:  

Mesh:

Year:  2011        PMID: 21532482     DOI: 10.1097/YCO.0b013e3283476b21

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  6 in total

1.  Health care expenditures of overweight and obese U.S. adults with intellectual and developmental disabilities.

Authors:  Henan Li; Glenn Fujiura; Sandra Magaña; Susan Parish
Journal:  Res Dev Disabil       Date:  2018-02-07

Review 2.  A clinical primer on intellectual disability.

Authors:  Dilip R Patel; Maria Demma Cabral; Arlene Ho; Joav Merrick
Journal:  Transl Pediatr       Date:  2020-02

3.  Prevalence and treatment of diabetes mellitus and hypertension among older adults with intellectual disability in comparison with the general population.

Authors:  Anna Axmon; Gerd Ahlström; Peter Höglund
Journal:  BMC Geriatr       Date:  2017-11-23       Impact factor: 3.921

4.  Prescription of potentially inappropriate medications among older people with intellectual disability: a register study.

Authors:  Anna Axmon; Magnus Sandberg; Gerd Ahlström; Patrik Midlöv
Journal:  BMC Pharmacol Toxicol       Date:  2017-10-25       Impact factor: 2.483

5.  Chronic Respiratory Disorders and Their Treatment among Older People with Intellectual Disability and/or Autism Spectrum Disorder in Comparison with the General Population.

Authors:  Anna Axmon; Peter Höglund; Gerd Ahlström
Journal:  Healthcare (Basel)       Date:  2017-08-01

6.  Clinical Characteristics and Pharmacological Treatment of Individuals With and Without Intellectual Disability in Pre-trial Assessment-A Population-Based Study.

Authors:  Hanna Edberg; Qi Chen; Peter Andiné; Henrik Larsson; Tatja Hirvikoski
Journal:  Front Psychiatry       Date:  2020-10-23       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.